Post-hoc Analysis of the Effects of Belimumab on Musculoskeletal Organ Manifestations in BILAG in the Phase-3-Trials with Belimumab

被引：0
|
作者：
Hiepe, F. [1 ]
Fischer-Betz, R. [2 ]
Schwarting, A. [3 ,4 ]
机构：
[1] Charite, Med Klin Schwerpunkt Rheumatol & Klin Immunol, D-13353 Berlin, Germany
[2] Univ Dusseldorf, Poliklin Rheumatol, Dusseldorf, Germany
[3] Univ Mainz Klinikum, Bad Kreuznach, Germany
[4] ACURA Rheumazentrum Rheinland Pfalz AG, Bad Kreuznach, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [1] POST-HOC ANALYSIS TO ASSESS EFFECT OF BELIMUMAB IN PATIENTS ON MYCOPHENOLATE MOFETIL WITH RENAL MANIFESTATIONS AT BASELINE
    Houssiau, F.
    Dooley, M. A.
    Aranow, C.
    D'Cruz, D.
    Askanase, A.
    Roth, D. A.
    Cooper, S.
    Zhong, Z. J.
    Freimuth, W.
    Ginzler, E. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 536 - 536
  • [2] PREDICTORS OF RENAL FLARES IN SYSTEMIC LUPUS ERYTHEMATOSUS: A POST-HOC ANALYSIS OF FOUR PHASE III CLINICAL TRIALS OF BELIMUMAB
    Jagerback, S.
    Gomez, A.
    Parodis, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 34
  • [3] Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab
    Jagerback, Sandra
    Gomez, Alvaro
    Parodis, Ioannis
    RHEUMATOLOGY, 2024,
  • [4] Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials
    Grosso, Giorgia
    Giannopoulou, Nefeli
    Tsoi, Alexander
    Cetrez, Nursen
    Nikolopoulos, Dionysis
    Lindblom, Julius
    Parodis, Ioannis
    RHEUMATOLOGY, 2025,
  • [5] Belimumab Effects on Skin in Patients with Systemic Lupus Erythematosus: A Pooled Post Hoc Analysis of Five Phase 3, Randomized, Placebo-Controlled Clinical Trials
    Manzi, Susan
    Sanchez-Guerrero, Jorge
    Yokogawa, Naoto
    Wenzel, Joerg
    Ocran-Appiah, Josephine C.
    Khamashta, Munther
    Harris, Julia H. N.
    Rubin, Bernie
    Fox, Norma Lynn
    Levy, Roger A.
    Werth, Victoria
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1933 - 1935
  • [6] Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus
    Chatzidionysiou, Katerina
    Samoli, Evangelia
    Sfikakis, Petros P.
    Tektonidou, Maria G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (02) : 304 - +
  • [7] Post Hoc British Isles Lupus Assessment Group Index Mucocutaneous Organ Domain Item Analysis of Systemic Lupus Erythematosus Patients Treated in Phase 3 Belimumab Clinical Trials.
    Manzi, Susan
    Gladman, Dafna
    Navarra, Sandra
    Sanchez-Guerrero, Jorge
    D'Cruz, David
    Freimuth, William
    Zhong, Z. John
    Keenan, Greg
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S231 - S231
  • [8] Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab
    Parodis, Ioannis
    Gomez, Alvaro
    Chow, Jun Weng
    Borg, Alexander
    Lindblom, Julius
    Gatto, Mariele
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
    Furie, Richard
    Petri, Michelle A.
    Strand, Vibeke
    Gladman, Dafna D.
    Zhong, Z. John
    Freimuth, William W.
    LUPUS SCIENCE & MEDICINE, 2014, 1 (01):
  • [10] Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
    Gallo, Silvina
    Calle, Roberto A.
    Terra, Steven G.
    Pong, Annpey
    Tarasenko, Lisa
    Raji, Annaswamy
    DIABETES THERAPY, 2020, 11 (08) : 1849 - 1860
12345